IBIO

iBio Stock Price

1.51
0.05 (3.42%)
Upgrade to Real-Time
Afterhours (Closed)
1.51
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
iBio Inc IBIO AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
0.05 3.42% 1.51 17:00:00
Open Price Low Price High Price Close Price Previous Close
1.41 1.40 1.53 1.51 1.46
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
14,663 6,770,277 $ 1.46 $ 9,853,191 7,255,415 0.106 - 7.85
Last Trade Time Type Quantity Stock Price Currency
17:00:00 16,849 $ 1.51 USD

iBio Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 274.98M 182.11M 181.52M $ 1.64M $ - -0.83 -2.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 4.10%

more financials information »

iBio News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical IBIO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.611.621.401.4911,103,114-0.10-6.21%
1 Month1.712.111.401.688,357,620-0.20-11.7%
3 Months1.802.621.402.0010,214,112-0.29-16.11%
6 Months1.607.851.313.1721,091,802-0.09-5.63%
1 Year0.11127.850.1062.2220,439,7361.401,257.91%
3 Years2.8287.850.052.177,290,034-1.32-46.61%
5 Years6.507.9970.052.224,475,357-4.99-76.77%

iBio Description

iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates. Its products are used to combat various areas such as fibrotic diseases, cancers, and infectious diseases. The company operates in two segments: biologics development and licensing activities, conducted within iBio, Inc.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.